Kazia Therapeutics Limited

Entity > Corporation > US > New York City New York > Kazia Therapeutics Limited

About Kazia Therapeutics Limited

Kazia Therapeutics Limited is an oncology-focused biotechnology company developing innovative anti-cancer drugs. Kazia Therapeutics Limited collaborates with leading scientists, clinicians and investors around the world.

Kazia Therapeutics Limited Welcomes Opportunities to Potential In-licensing of Development Candidates for Oncology Indications: Our primary focus is on small molecule therapies, with a preference for those that can be orally administered and handled under controlled ambient conditions. Kazia Therapeutics Limited are able to work in all cancer types, but with a focus on solid tumour indications. Kazia Therapeutics Limited are excited about development candidates with first-in-class or best-in-class potential, where there is clear target validation, compelling proof of concept in vivo, a mature GMP manufacturing process, and availability of some GLP toxicology data.

Kazia Therapeutics Limited’s Founding And Headquarters: Kazia Therapeutics Limited was founded in 1994 by Graham Kelly. Kazia Therapeutics Limited is currently headquartered in Hornsby, New South Wales, Australia.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Kazia Therapeutics Limited

Company Attribute Value
Address StreetAddress: 300 Barangaroo Ave L 24, AddressLocality: Sydney, AddressRegion: New South Wales, PostalCode: 2000, AddressCountry: Australia
Founding Date 1992
Name Kazia Therapeutics Limited
Number Of Employees 8
Revenue $10,550,000 USD
Ticker Symbol NASDAQ: KZIA
Url kaziatherapeutics
Facebook facebook
Linkedin linkedin
Twitter twitter
Google google

Kazia Therapeutics Limited


New York City, US
18 Feb 2024

New York City, US
18 Feb 2024

Kazia Therapeutics Limited

Page: 1 Desktop | Laptop Devices

Kazia Therapeutics Limited
https://finance.yahoo.com › quote › KZIA
Kazia Therapeutics Limited (KZIA) Stock Price, News ...
https://www.prnewswire.com › news-releases › kazia-t...
Kazia Therapeutics Announces Closing of $2 Million ...
Kazia Therapeutics Limited
https://www.annualreports.com › Company › kazia-th...
Kazia Therapeutics Limited
https://www.marketwatch.com › ... › Quotes › ADRs
Kazia Therapeutics Ltd. ADR Stock Quote (U.S. - KZIA
https://finance.yahoo.com › quote › KZIA › profile
Kazia Therapeutics Limited (KZIA) Company Profile & Facts
https://www.stocktitan.net › News
Kazia Therapeutics Limited (KZIA) Stock News
Related Searches
Related Searches
Kazia therapeutics limited share price
Kazia therapeutics limited reviews
Kazia therapeutics limited stock
Knowledge Panel
Knowledge Panel

Kazia Therapeutics (Biotechnology company)


Kazia Therapeutics Limited (ASX: KZA, NASDAQ: KZIA) is an innovative oncology-focused biotechnology company, based in Sydney, Australia. Their pipeline includes two clinical-stage drug development candidates, and they are working to develop therapies across a range of oncology indications.

  • Stock price : KZIA (NASDAQ) $0.35 +0.04 (+13.92%)Feb 16, 4:00 PM EST - Disclaimer
  • Headquarters : New South Wales, Australia
  • Subsidiaries : Glycotex, Inc., Novogen Research Pty Ltd., MORE
  • Founded : 1994

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 194140